Site Logo
  1. Home
  2. Past Issues
  3. Summary Vol.88 Issue 2 / 2025
  4. Article
Original Articles
Visualizações

Arq. Bras. Oftalmol. 2025; 88 (2): 10.5935/0004-2749.2023-0229

Total: 2049

Should intravitreal dexamethasone implant in refractory diabetic macular edema be used as an adjuvant therapy or switch therapy?

Semih Çakmak1; Gokhan Demir2; Uğur Tunç3; Elmas Yuksel Sukun4; Yusuf Berk Akbas5; Abdullah Ozkaya6; Ozgur Artunay7; Gurkan Erdogan1

DOI: 10.5935/0004-2749.2023-0229


THE CONTENT OF THIS ARTICLE IS NOT AVAILABLE FOR THIS LANGUAGE.


Print PDF English
Open Access
Share

How to cite this article:

Çakmak S, Demir G, Tunç U, Sukun EY, Akbas YB, Ozkaya A, et al. Should intravitreal dexamethasone implant in refractory diabetic macular edema be used as an adjuvant therapy or switch therapy?. Arq. Bras. Oftalmol. 2025;88(2): e2023-0229:1-6. 10.5935/0004-2749.2023-0229
Export citation